Delivery Order SPE2DB20D3104-SPE2DB21FV9C9
- Not listed
- This federal contract award, valued at $1,104.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.06 delivery order is for the supply of the medication Junel FE 1.5 mg-30 mcg tablet, 28s, with a completion date of December 20, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award is a delivery order valued at $1,167.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Junel FE 1 mg-20 mcg tablets, a generic oral contraceptive, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1.5 mg-30 mcg tablets. The contract, valued at $2,452.14, is a firm fixed-price delivery order that was awarded on March 25, 2022 with a completion date of March 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,104.48 firm fixed price delivery order is for the supply of Junel FE 1 mg-20 mcg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,693.55 firm fixed-price delivery order is for the supply of the medication Junel FE 1.5 mg-30 mcg tablet, 28s. The contract has an ultimate completion date of April 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,657.35 firm fixed-price delivery order is for the supply of the drug Junel FE 1.5 mg-30 mcg tablets, with an ultimate completion date of October 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,192.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the pharmaceutical product JUNEL FE 1 MG-20 MCG TABLET 28S. The contract has an ultimate completion date of May 20, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,240.80 firm fixed-price delivery order is for the pharmaceutical product JUNEL FE 1.5 MG-30 MCG TABLET 28S. The contract has an ultimate completion date of July 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.88 Firm Fixed Price Delivery Order covers the supply of the pharmaceutical product "JUNEL FE 1 MG-20 MCG TABLET 28S" with a completion date of December 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV9C9Delivery Order
This federal contract award, valued at $1,344.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of August 4, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract does not have a set-aside designation, indicating it was awarded through full and open competition. In addition to this specific delivery order, Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/3/21 |